Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-06-07
1998-09-08
Shippen, Micahel L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514554, 514562, A61K 31495
Patent
active
058045821
ABSTRACT:
New crystalline organic salts of N,N'-diacetyl cystine with immunomodulating effect, processes for their preparation, pharmaceutical compositions containing them and methods of their pharmacological use.
REFERENCES:
patent: 3647834 (1972-03-01), Martin
patent: 3878305 (1975-04-01), Damico
patent: 3952115 (1976-04-01), Damico
patent: 4093739 (1978-06-01), Martin
patent: 4141734 (1979-02-01), Lenoir
patent: 4241086 (1980-12-01), Iwao
patent: 4708965 (1987-11-01), Morgan
patent: 4724239 (1988-02-01), Morgan
patent: 4801579 (1989-01-01), Rainer
patent: 4827016 (1989-05-01), Morgan
patent: 4859653 (1989-08-01), Morelle
Marshall, et al. "Preparation and Properties of the Isomeric Forms of Crystine and S-Benzylpenicillamine," J. Amer. Chem. Soc. 79: 4538-4544, 1957.
Greenstein, et al. "Ammonia Formation from Cystine Peptides and Dehydropeptides in Rat Liver Digests," Arch. of Biochem. 18: 377-82, 1948.
Andersson Carl-Magnus Alexander
Bergstrand H.ang.kan Sten Axel Magnus
Jakupovic Edib
Josefsson Bo-Goran
Lindvall Magnus Leif
Astra Aktiebolag
Shippen Micahel L.
LandOfFree
Method for the treatment of diseases due to defects the immune s does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for the treatment of diseases due to defects the immune s, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the treatment of diseases due to defects the immune s will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1282363